Tag: hormoneReplacementTherapy

Articles

• Dietary fiber is associated with reduced risk of breast cancer
• ER+/PR+ breast cancer
• ER+/PR- breast cancer
• How can young breast cancer survivors avoid a recurrence?
• How does birth control pill use influence breast cancer risk?
• Latest research concerning breast cancer in Asian Americans
• Latest research concerning breast density and breast cancer
• Latest research concerning lobular breast cancer prognosis
• Latest research on hormone replacement therapy and breast cancer
• Lobular breast cancer and LCIS
• What should breast cancer patients and survivors eat during tamoxifen treatment?
• What should breast cancer patients eat during Adriamycin (doxorubicin) chemotherapy?
• What should breast cancer survivors eat during aromatase inhibitor treatment?
• What should ER+/PR- breast cancer patients and survivors eat?
• What should lobular breast cancer patients and survivors eat?

News

• Apigenin may prevent breast cancer that develops in response to progestin
• Benign breast disease least likely to progress to breast cancer in those having children while young
• Beta-carotene, vitamin A and vitamin E do not reduce risk of breast cancer?
• Breast tenderness from combination hormone replacement therapy (HRT) predicts breast cancer
• Carotenoids in food reduce risk of breast cancer and recurrence
• Combination HRT doubles breast cancer risk among women with breast tenderness
• Combined HRT increase risk of lymph node positive breast cancer
• Dense breasts are linked to increased risk of hormone receptor positive and mixed receptor tumors
• Does sitting for long periods of time increase breast cancer risk?
• Drop in hormone replacement therapy use explains part of decline in breast cancer rates
• Estrogen only and combined HRT both increase risk of breast cancer
• Estrogen-only HRT may be protective against breast cancer
• High circulating estrogen and androgen increase risk of postmenopausal breast cancer
• High circulating hormones increase risk of breast cancer for postmenopausal women
• Hot flashes in breast cancer survivors can be managed with antidepressant
• HRT increases risk of breast cancer, especially for those with dense breasts
• Intense hot flashes at menopause linked to lower breast cancer risk
• Less HRT use after 2002 translated into fewer breast cancer cases among Canadian women
• Loss of spouse does not increase risk of breast cancer recurrence
• Metformin reduces risk of ER+/PR+ breast cancer in postmenopausal women
• Migraine sufferers have lower risk of ER+/PR+ tumors - implications for choice of treatment
• Obesity reduces survival after diagnosis and exercise does not improve prognosis
• Some breast cancer risk factors differently influence ductal and lobular breast cancer
• Soy supplements do not reduce breast cancer risk and could be harmful
• The antidepressant Paxil reduces the effectiveness of tamoxifen treatment
• Three cases of inflammatory breast cancer in one office suggest environmental causes
• Weight gain during adulthood increases risk of postmenopausal breast cancer

Foods

• alcohol  flaxseed 

Studies

• A case-control study on hormone therapy as a risk factor for breast cancer in Finland: Intrauterine system carries a risk as well
• A cluster of inflammatory breast cancer (IBC) in an office setting: additional evidence of the importance of environmental factors in IBC etiology
• Age and Menopausal Effects of Hormonal Birth Control and Hormone Replacement Therapy in Relation to Breast Cancer Risk
• Apigenin Induces Apoptosis and Blocks Growth of Medroxyprogesterone Acetate-Dependent BT-474 Xenograft Tumors
• Apigenin prevents development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats
• Association of Hormone-Related Characteristics and Breast Cancer Risk by Estrogen Receptor/Progesterone Receptor Status in the Shanghai Breast Cancer Study
• Body mass index (BMI), change in BMI, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)
• Body size and the risk of postmenopausal breast cancer subtypes in the California Teachers Study cohort
• Breast Cancer Incidence and Hormone Replacement Therapy in Canada
• Breast cancer patients with lobular cancer more commonly have a father than a mother diagnosed with cancer
• Breast Cancer Risk by Breast Density, Menopause, and Postmenopausal Hormone Therapy Use
• Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women’s health initiative clinical trials
• Change in mammographic density with estrogen and progestin therapy: A measure of breast cancer risk in the Women’s Health Initiative
• Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial
• Curcumin delays development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumors
• Dietary β-carotene, vitamin C and E intake and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition
• Dietary carbohydrates and breast cancer risk: A prospective study of the roles of overall glycemic index and glycemic load
• Dual Estrogen Effects on Breast Cancer: Endogenous Estrogen Stimulates, Exogenous Estrogen Protects. Further Investigation of Estrogen Chemoprevention Is Warranted
• Effect of oral phytoestrogen on androgenicity and insulin sensitivity in postmenopausal women
• Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal Women
• Estrogen-Progestagen Menopausal Hormone Therapy and Breast Cancer: Does Delay From Menopause Onset to Treatment Initiation Influence Risks?
• Hops (Humulus lupulus) Inhibits Oxidative Estrogen Metabolism and Estrogen-Induced Malignant Transformation in Human Mammary Epithelial cells (MCF-10A)
• Hormone therapy and risk for breast cancer in Finnish postmenopausal women
• Hormone Treatment, Estrogen Receptor Polymorphisms and Mortality: A Prospective Cohort Study
• Hot flashes, hormone therapy, and breast cancer risk: The Women’s Health Initiative Clinical Trials
• Intake of whole grain products and risk of breast cancer by hormone receptor status and histology among postmenopausal women
• Interactions between intakes of alcohol and postmenopausal hormones on risk of breast cancer
• Long-term use of hormone therapy and breast cancer incidence and mortality
• Mammographic breast density and breast cancer risk by menopausal status, postmenopausal hormone use and a family history of breast cancer
• Mammographic Density, Response to Hormones, and Breast Cancer Risk
• Meat Intake and Mortality
• Menopausal hormone therapy and breast cancer risk: Impact of different treatments. The European prospective investigation into cancer and nutrition (EPIC)
• Modifiable risk factors and survival in women diagnosed with primary breast cancer: results from a prospective cohort study
• Multicenter, Randomized, Cross-Over Clinical Trial of Venlafaxine Versus Gabapentin for the Management of Hot Flashes in Breast Cancer Survivors
• New-Onset Breast Tenderness After Initiation of Estrogen Plus Progestin Therapy and Breast Cancer Risk
• No Difference Between Red Wine or White Wine Consumption and Breast Cancer Risk
• Physical activity, sitting time, and postmenopausal breast cancer risk by histopathologic characteristics in a large US cohort
• Prospective study of the association between grapefruit intake and risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)
• Relationship between Menopausal Symptoms and Risk of Postmenopausal Breast Cancer
• Risk Factors for Ductal, Lobular, and Mixed Ductal-Lobular Breast Cancer in a Screening Population
• Risk factors for postmenopausal breast cancer defined by estrogen and progesterone receptor status: The multiethnic cohort
• Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial
• Screening Mammography Use among Current, Former, and Never Hormone Therapy Users May Not Explain Recent Declines in Breast Cancer Incidence
• Soy Isoflavones in the Prevention of Menopausal Bone Loss and Menopausal Symptoms
• Statins and breast cancer in postmenopausal women without hormone therapy
• The Changing Incidence of In situ and Invasive Ductal and Lobular Breast Carcinomas: United States, 1999-2004
• The Use of Herbal Preparations to Alleviate Climacteric Disorders and Risk of Postmenopausal Breast Cancer in a German Case-Control Study
• Tibolone increases bone mineral density but also relapse in breast cancer survivors: LIBERATE Trial Bone Sub-study
• ZEN and the art of breast health maintenance